Paper29259986
Apoptotic Signaling Pathways in Glioblastoma and Therapeutic Implications.
Valdés-Rives SA and 4 others. Biomed Res Int, 2017. Cited by 87 papers, by iCite.
Cite this record
ConductScience Library. Apoptotic Signaling Pathways in Glioblastoma and Therapeutic Implications. Papers, record 29259986. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29259986
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Apoptosis | Major topic |
| Cell Movement | Major topic |
| Cell Proliferation | Major topic |
| Glioblastoma | Major topic |
| Humans | |
| Neoplasm Invasiveness | |
| Signal Transduction |
Source PubMed
References107
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15184909 | Analysis of the activation status of Akt, NFkappaB, and Stat3 in human diffuse gliomas. | Lab Invest | 2004 | https://conductscience.org/library/papers/15184909 | PubMed |
| 2 | 24944883 | Tumor suppressive miRNA-34a suppresses cell proliferation and tumor growth of glioma stem cells by targeting Akt and Wnt signaling pathways. | FEBS Open Bio | 2014 | https://conductscience.org/library/papers/24944883 | PubMed |
| 3 | 11381677 | Expression of nuclear factor-kappa B, tumor necrosis factor receptor type 1, and c-Myc in human astrocytomas. | Neurol Med Chir (Tokyo) | 2001 | https://conductscience.org/library/papers/11381677 | PubMed |
| 4 | 24507955 | Cancer therapeutics: Targeting the apoptotic pathway. | Crit Rev Oncol Hematol | 2014 | https://conductscience.org/library/papers/24507955 | PubMed |
| 5 | 28212562 | Overexpression of miR-29a reduces the oncogenic properties of glioblastoma stem cells by downregulating Quaking gene isoform 6. | Oncotarget | 2017 | https://conductscience.org/library/papers/28212562 | PubMed |
| 6 | 10914698 | Temozolomide and treatment of malignant glioma. | Clin Cancer Res | 2000 | https://conductscience.org/library/papers/10914698 | PubMed |
| 7 | 21968049 | Antitumor effect of dehydroxymethylepoxyquinomicin, a small molecule inhibitor of nuclear factor-κB, on glioblastoma. | Neuro Oncol | 2012 | https://conductscience.org/library/papers/21968049 | PubMed |
| 8 | 20624968 | Arsenic antagonizes the Hedgehog pathway by preventing ciliary accumulation and reducing stability of the Gli2 transcriptional effector. | Proc Natl Acad Sci U S A | 2010 | https://conductscience.org/library/papers/20624968 | PubMed |
| 9 | 24607407 | Osteopontin-CD44 signaling in the glioma perivascular niche enhances cancer stem cell phenotypes and promotes aggressive tumor growth. | Cell Stem Cell | 2014 | https://conductscience.org/library/papers/24607407 | PubMed |
| 10 | 23378584 | Multiple functions of BCL-2 family proteins. | Cold Spring Harb Perspect Biol | 2013 | https://conductscience.org/library/papers/23378584 | PubMed |
| 11 | 8261449 | Subcellular localization of the bcl-2 protein in malignant and normal lymphoid cells. | Cancer Res | 1994 | https://conductscience.org/library/papers/8261449 | PubMed |
| 12 | 23603977 | NVP-BEZ235, a novel dual PI3K/mTOR inhibitor, enhances the radiosensitivity of human glioma stem cells in vitro. | Acta Pharmacol Sin | 2013 | https://conductscience.org/library/papers/23603977 | PubMed |
| 13 | 21879257 | MicroRNA-125b-2 confers human glioblastoma stem cells resistance to temozolomide through the mitochondrial pathway of apoptosis. | Int J Oncol | 2012 | https://conductscience.org/library/papers/21879257 | PubMed |
| 14 | 22236189 | Deregulated signaling pathways in glioblastoma multiforme: molecular mechanisms and therapeutic targets. | Cancer Invest | 2012 | https://conductscience.org/library/papers/22236189 | PubMed |
| 15 | 24552816 | Distinctive effects of the cellular inhibitor of apoptosis protein c-IAP2 through stabilization by XIAP in glioblastoma multiforme cells. | Cell Cycle | 2014 | https://conductscience.org/library/papers/24552816 | PubMed |
| 16 | 23533755 | Inhibition of NF- κ B by Dehydroxymethylepoxyquinomicin Suppresses Invasion and Synergistically Potentiates Temozolomide and γ -Radiation Cytotoxicity in Glioblastoma Cells. | Chemother Res Pract | 2013 | https://conductscience.org/library/papers/23533755 | PubMed |
| 17 | 25051975 | The mTOR kinase inhibitors polarize glioma-activated microglia to express a M1 phenotype. | J Neuroinflammation | 2014 | https://conductscience.org/library/papers/25051975 | PubMed |
| 18 | 27994508 | CRISPR-Cas9: from Genome Editing to Cancer Research. | Int J Biol Sci | 2016 | https://conductscience.org/library/papers/27994508 | PubMed |
| 19 | 25706986 | Metabolic reprogramming in mutant IDH1 glioma cells. | PLoS One | 2015 | https://conductscience.org/library/papers/25706986 | PubMed |
| 20 | 14634621 | The Bcl-2 family: roles in cell survival and oncogenesis. | Oncogene | 2003 | https://conductscience.org/library/papers/14634621 | PubMed |
Cited by63
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 87 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42794423 | Pulsed Electromagnetic Fields Enhance Resveratrol-Induced Apoptosis Through Modulation of Apoptotic Signaling in U87-MG Glioblastoma Cells. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42794423 | PubMed |
| 42381706 | Pyroptosis as a novel therapeutic target in glioblastoma multiforme: Mechanisms, molecular insights, and therapeutic potential. | Mol Ther Nucleic Acids | 2026 | https://conductscience.org/library/papers/42381706 | PubMed |
| 42043033 | Advances in Targeted Toxin Therapy for Malignant Gliomas: A Narrative Review. | Toxins (Basel) | 2026 | https://conductscience.org/library/papers/42043033 | PubMed |
| 41979920 | SCD1 and SCD5 modulate PARP-dependent DNA repair via fatty acid desaturation in glioblastoma. | Cell Rep | 2026 | https://conductscience.org/library/papers/41979920 | PubMed |
| 41958080 | The GPCR Connection: Linking Alzheimer's Disease and Glioblastoma. | J Cell Mol Med | 2026 | https://conductscience.org/library/papers/41958080 | PubMed |
| 41828436 | Overcoming Chemoresistance in Glioblastoma: Mechanisms, Therapeutic Strategies, and Functional Precision Medicine. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41828436 | PubMed |
| 41281928 | Drug resistance in glioblastoma: Challenges, mechanisms and therapeutic strategies (Review). | Mol Clin Oncol | 2026 | https://conductscience.org/library/papers/41281928 | PubMed |
| 41008904 | Targeting the Mitochondria in High-Grade Gliomas. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41008904 | PubMed |
| 40822033 | Ferroptosis as a therapeutic target in glioblastoma: Mechanisms and emerging strategies. | Mol Ther Nucleic Acids | 2025 | https://conductscience.org/library/papers/40822033 | PubMed |
| 40518661 | Quantitative Proteomic Analysis Reveals Different Functional Subtypes among IDH-Wildtype Glioblastoma. | J Proteome Res | 2025 | https://conductscience.org/library/papers/40518661 | PubMed |
| 40293574 | Doxorubicin and NFL-TBS.40-63 peptide loaded gold nanoparticles as a multimodal therapy of glioblastoma. | Discov Nano | 2025 | https://conductscience.org/library/papers/40293574 | PubMed |
| 39827337 | Chitinase-3-like-1: a multifaceted player in neuroinflammation and degenerative pathologies with therapeutic implications. | Mol Neurodegener | 2025 | https://conductscience.org/library/papers/39827337 | PubMed |
| 39668701 | Beta-Caryophyllene Augments Radiotherapy Efficacy in GBM by Modulating Cell Apoptosis and DNA Damage Repair via PPARγ and NF-κB Pathways. | Phytother Res | 2025 | https://conductscience.org/library/papers/39668701 | PubMed |
| 39507759 | Curcumin as a novel therapeutic candidate for cancer: can this natural compound revolutionize cancer treatment? | Front Oncol | 2024 | https://conductscience.org/library/papers/39507759 | PubMed |
| 39503973 | Cell death in glioblastoma and the central nervous system. | Cell Oncol (Dordr) | 2025 | https://conductscience.org/library/papers/39503973 | PubMed |
| 39296804 | Synergism of d-limonene and temozolomide on migratory and apoptotic behaviors of human glioblastoma cell lines. | Bioimpacts | 2024 | https://conductscience.org/library/papers/39296804 | PubMed |
| 39045029 | Combining the constitutive TRAIL-secreting induced neural stem cell therapy with the novel anti-cancer drug TR-107 in glioblastoma. | Mol Ther Oncol | 2024 | https://conductscience.org/library/papers/39045029 | PubMed |
| 38698968 | Immunogenic cell death mediated TLR3/4-activated MSCs in U87 GBM cell line. | Heliyon | 2024 | https://conductscience.org/library/papers/38698968 | PubMed |
| 38686058 | A review on potential heterocycles for the treatment of glioblastoma targeting receptor tyrosine kinases. | Oncol Res | 2024 | https://conductscience.org/library/papers/38686058 | PubMed |
| 38607071 | A Novel Approach for Glioblastoma Treatment by Combining Apoptosis Inducers (TMZ, MTX, and Cytarabine) with E.V.A. (Eltanexor, Venetoclax, and A1210477) Inhibiting XPO1, Bcl-2, and Mcl-1. | Cells | 2024 | https://conductscience.org/library/papers/38607071 | PubMed |
Genes79
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29259986
GET https://conductscience.org/api/papers/v1/29259986/references?page=2